Effects of Vitamin D on Cardiac Function in Patients With Chronic HF: The VINDICATE Study

Journal of the American College of Cardiology

Volumn 67, Issue 22, 2016, Pages 2593-2603

  Witte, Klaus K ^a   Byrom, Rowena ^a   Gierula, John ^a   Paton, Maria F ^a   Jamil, Haqeel A ^a   Lowry, Judith E ^a   Gillott, Richard G ^b   Barnes, Sally A ^b   Chumun, Hemant ^a   Kearney, Lorraine C ^a   Greenwood, John P ^a   Plein, Sven ^a   Law, Graham R ^a   Pavitt, Sue ^a   Barth, Julian H ^b   Cubbon, Richard M ^a   Kearney, Mark T ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b LEEDS TEACHING HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

heart failure; left ventricular function; remodeling; vitamin D

Indexed keywords

CALCITRIOL; COLECALCIFEROL; PARATHYROID HORMONE; CALCIFEDIOL; VITAMIN;

ARTICLE; CALCIUM BLOOD LEVEL; CARDIOVASCULAR RESPONSE; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; HEART FAILURE; HEART FUNCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; HYPERCALCEMIA; HYPERVITAMINOSIS; MAJOR CLINICAL STUDY; MALE; PARATHYROID HORMONE BLOOD LEVEL; PRIORITY JOURNAL; PROGNOSIS; TREATMENT DURATION; TREATMENT OUTCOME; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION; AGED; BLOOD; CINE MAGNETIC RESONANCE IMAGING; COMPLICATION; DIAGNOSTIC IMAGING; DOUBLE BLIND PROCEDURE; DRUG EFFECTS; ECHOCARDIOGRAPHY; FEMALE; HEART LEFT VENTRICLE FUNCTION; HEART STROKE VOLUME; HEART VENTRICLE; HEART VENTRICLE REMODELING; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL; SYSTOLE; WALK TEST;

AGED; CALCIFEDIOL; CALCITRIOL; CHOLECALCIFEROL; DOUBLE-BLIND METHOD; ECHOCARDIOGRAPHY; FEMALE; HEART FAILURE; HEART VENTRICLES; HUMANS; MAGNETIC RESONANCE IMAGING, CINE; MALE; MIDDLE AGED; STROKE VOLUME; SYSTOLE; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR REMODELING; VITAMINS; WALK TEST;

EID: 84975038954     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2016.03.508     Document Type: Article

References (44)

1. 1 Heidenreich, P.A., Albert, N.M., Allen, L.A., et al. Forecasting the impact of heart failure in the United States: a policy statement from the American Heart Association. Circ Heart Fail 6 (2013), 606–619.
2. 2 Mosterd, A., Hoes, A.W., Clinical epidemiology of heart failure. Heart 93 (2007), 1137–1146.
3. 3 Cubbon, R.M., Gale, C.P., Kearney, L.C., et al. Changing characteristics and mode of death associated with chronic heart failure caused by left ventricular systolic dysfunction: a study across therapeutic eras. Circ Heart Fail 4 (2011), 396–403.
4. 4 Barker, W.H., Mullooly, J.P., Getchell, W., Changing incidence and survival for heart failure in a well-defined older population, 1970–1974 and 1990–1994. Circulation 113 (2006), 799–805.
5. 5 Jhund, P.S., Macintyre, K., Simpson, C.R., et al. Long-term trends in first hospitalization for heart failure and subsequent survival between 1986 and 2003: a population study of 5.1 million people. Circulation 119 (2009), 515–523.
6. 6 Zittermann, A., Schleithoff, S.S., Frisch, S., et al. Circulating calcitriol concentrations and total mortality. Clin Chem 55 (2009), 1163–1170.
7. 7 Pilz, S., März, W., Wellnitz, B., et al. Association of vitamin D deficiency with heart failure and sudden cardiac death in a large cross-sectional study of patients referred for coronary angiography. J Clin Endocrinol Metab 93 (2008), 3927–3935.
8. 8 Schierbeck, L.L., Jensen, T.S., Bang, U., Jensen, G., Kober, L., Jensen, J.E., Parathyroid hormone and vitamin D—markers for cardiovascular and all-cause mortality in heart failure. Eur J Heart Fail 13 (2011), 626–632.
9. 9 Liu, L., Chen, M., Hankins, S.R., et al. Serum 25-hydroxyvitamin D concentration and mortality from heart failure and cardiovascular disease, and premature mortality from all-cause in United States adults. Am J Cardiol 110 (2012), 834–839.
10. 10 Ford, J.A., MacLennan, G.S., Avenell, A., et al. Cardiovascular disease and vitamin D supplementation: trial analysis, systematic review, and meta-analysis. Am J Clin Nutr 100 (2014), 746–755.
11. 11 Kim, D.H., Sabour, S., Sagar, U.N., Adams, S., Whellan, D.J., Prevalence of hypovitaminosis D in cardiovascular disease (from the National Health and Nutrition Examination Survey 2001-2004). Am J Cardiol 102 (2008), 1540–1544.
12. 12 Ameri, P., Ronco, D., Casu, M., et al. High prevalence of vitamin D deficiency and its association with left ventricular dilation: an echocardiography study in elderly patients with chronic heart failure. Nutr Metab Cardiovasc Dis 20 (2010), 633–640.
13. 13 Witte, K.K., Byrom, R., Micronutrients for chronic heart failure: end of the road or path to enlightenment?. J Am Coll Cardio HF 2 (2014), 318–320.
14. 14 Gardner, D.G., Chen, S., Glenn, D.J., Vitamin D and the heart. Am J Physiol Regul Integr Comp Physiol 305 (2013), R969–R977.
15. 15 Schleithoff, S.S., Zittermann, A., Tenderich, G., et al. Vitamin D supplementation improves cytokine profiles in patients with congestive heart failure: a double-blind, radomized, placebo-controlled trial. Am J Clin Nutr 83 (2006), 754–759.
16. 16 Witham, M.D., Crighton, L.J., Gillespie, N.D., Struthers, A.D., McMurdo, M.E., The effects of vitamin D supplementation on physical function and quality of life in older patients with heart failure: a randomized controlled trial. Circ Heart Fail 3 (2010), 195–201.
17. 17 Vasquez, A., Cannell, J., Calcium and vitamin D in preventing fractures: data are not sufficient to show inefficacy. BMJ 331 (2005), 108–109.
18. 18 Ahokas, R.A., Sun, Y., Bhattacharya, S.K., Gerling, I.C., Weber, K.T., Aldosteronism and a proinflammatory vascular phenotype. Role of Mg2+, Ca2+ and H2O2 in peripheral blood mononuclear cells. Circulation 111 (2005), 51–57.
19. 19 Lowry, J., Gierula, J., Byrom, R., et al. Vitamin d supplementation improves the size and function of the left ventricle in patients with heart failure. Eur Heart J 36:Suppl 1 (2015), A665–A666.
20. 20 Olsson, L.G., Swedberg, K., Clark, A.L., Witte, K.K., Cleland, J.G., Six minute corridor walk test as an outcome measure for the assessment of treatment in randomized, blinded intervention trials of chronic heart failure: a systematic review. Eur Heart J 26 (2005), 778–793.
21. 21 Holick, M.F., Vitamin D deficiency. N Engl J Med 357 (2007), 266–281.
22. 22 Rosen, C.J., Clinical practice. Vitamin D insufficiency. N Engl J Med 364 (2011), 248–254.
23. 23 Lang, R.M., Badano, L.P., Mor-Avi, V., et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr 28 (2015), 1–39.
24. 24 Anker, S.D., Comin Colet, J., Filippatos, G., et al. Ferric carboxymaltose in patients with heart failure and iron deficiency. N Engl J Med 361 (2009), 2436–2448.
25. 25 Zhang, S., Paul, J., Nantha-Aree, M., et al. Empirical comparison of four baseline covariate adjustment methods in analysis of continuous outcomes in randomized controlled trials. Clin Epidemiol 6 (2014), 227–235.
26. 26 Zittermann, A., Fischer, J., Schleithoff, S.S., et al. Patients with congestive heart failure and healthy controls differ in vitamin D-associated lifestyle factors. Int J Vitam Nutr Res 77 (2007), 280–288.
27. 27 Begg, G.A., Cleland, J.G., Witte, K.K., Letter by Begg et al. regarding the article “The effects of vitamin D supplementation on physical function and quality of life in older heart failure patients: a randomized controlled trial.”. Circ Heart Fail, 3, 2010, e24.
28. 28 Boxer, R.S., Hoit, B.D., Schmotzer, B.J., Stefano, G.T., Gomes, A., Negrea, L., The effect of vitamin d on aldosterone and health status in patients with heart failure. J Card Fail 20 (2014), 334–342.
29. 29 Boxer, R.S., Kenny, A.M., Schmotzer, B.J., Vest, M., Fiutem, J.J., Piña, I.L., A randomized controlled trial of high dose vitamin D3 in patients with heart failure. J Am Coll Cardiol HF 1 (2013), 84–90.
30. 30 Schroten, N.F., Ruifrok, W.P., Kleijn, L., et al. Short-term vitamin D3 supplementation lowers plasma renin activity in patients with stable chronic heart failure: an open-label, blinded end point, randomized prospective trial (VitD-CHF trial). Am Heart J 166 (2013), 357–364.
31. 31 Dalbeni, A., Scaturro, G., Degan, M., Minuz, P., Delva, P., Effects of six months of vitamin D supplementation in patients with heart failure: a randomized double-blind controlled trial. Nutr Metab Cardiovasc Dis 24 (2014), 861–868.
32. 32 Mann, D.L., Bristow, M.R., Mechanisms and models in heart failure: the biomechanical model and beyond. Circulation 111 (2005), 2837–2849.
33. 33 Abdulla, J., Barlera, S., Latini, R., et al. A systematic review: effects of angiotensin converting enzyme inhibition on left ventricular volumes and ejection fraction in patients with a myocardial infarction and in patients with left ventricular dysfunction. Eur J Heart Fail 9 (2007), 129–135.
34. 34 Packer, M., Antonopoulos, G.V., Berlin, J.A., Chittams, J., Konstam, M.A., Udelson, J.E., Comparative effects of carvedilol and metoprolol on left ventricular ejection fraction in heart failure: results of a meta analysis. Am Heart J 141 (2001), 899–907.
35. 35 van de Ven, L.L., van Veldhuisen, D.J., Goulder, M., Zilahi, Z., Meyer, W.R., Willenheimer, R., The effect of treatment with bisoprolol-first versus enalapril-first on cardiac structure and function in heart failure. Int J Cardiol 144 (2010), 59–63.
36. 36 Foley, P.W., Chalil, S., Khadjooi, K., Irwin, N., Smith, R.E., Leyva, F., Left ventricular reverse remodelling, long-term clinical outcome, and mode of death after cardiac resynchronization therapy. Eur J Heart Fail 13 (2011), 43–51.
37. 37 Cohn, J.N., Ferrari, R., Sharpe, N., Cardiac remodelling—concept and clinical implications: a consensus paper from an international forum on cardiac remodelling. J Am Coll Cardiol 35 (2000), 569–582.
38. 38 Weisshaar, R.E., Simpson, R.U., Involvement of vitamin D3 with cardiovascular function II direct and indirect effects. Am J Physiol 253 (1987), E675–E683.
39. 39 Chen, S., Law, C.S., Grigsby, C.L., et al. Cardiomyocyte-specific deletion of the vitamin D receptor gene results in cardiac hypertrophy. Circulation 124 (2011), 1838–1847.
40. 40 Weber, K.T., Weglicki, W.B., Simpson, R.U., Macro- and micronutrient dyshomeostasis in the adverse structural remodelling of myocardium. Cardiovasc Res 81 (2009), 500–508.
41. 41 Artaza, J.N., Mehrotra, R., Norris, K.C., Vitamin D and the cardiovascular system. Clin J Am Soc Nephrol 4 (2009), 1515–1522.
42. 42 Konstam, M.A., Kramer, D.G., Patel, A.R., Maron, M.S., Udelson, J.E., Left ventricular remodeling in heart failure: current concepts in clinical significance and assessment. J Am Coll Cardiol Img 4 (2011), 98–108.
43. 43 Xiang, W., Kong, J., Chen, S., et al. Cardiac hypertrophy in vitamin D receptor knockout mice: role of the systemic and cardiac renin-angiotensin systems. Am J Physiol Endocrin Metab 288 (2005), E125–E132.
44. 44 Li, Y.C., Kong, J., Wei, M., Chen, Z.F., Liu, S.Q., Cao, L.P., 1,25-Dihydroxyvitamin D3 is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest 110 (2002), 229–238.